Mahmud R, Tingle M D, Maggs J L, Cronin M T, Dearden J C, Park B K
Department of Pharmacology and Therapeutics, University of Liverpool, UK.
Toxicology. 1997 Feb 14;117(1):1-11. doi: 10.1016/s0300-483x(96)03548-2.
The structural basis of dapsone (4,4'-diaminodiphenyl sulphone) haemotoxicity has been determined by investigation of the in vitro bioactivation of a series of 4-substituted arylamines. In the presence of rat liver microsomes, dapsone (100 microM) was the most potent former of methaemoglobin in human erythrocytes (44.8 +/- 6.7%). Substitution of the sulphone group with sulphur (11.6 +/- 1.4% methaemoglobin), oxygen (4.5 +/- 1.1%), nitrogen (0.0 +/- 3.2%), carbon (13.6 +/- 0.8%) or a keto group (34.0 +/- 6.1%) resulted in a decrease in methaemoglobin formation. Only one compound, 4,4'-diaminodiphenylamine, generated significant (P < 0.001) amounts of methaemoglobin (25.6 +/- 2.5%) in the absence of NADPH. To assess further the role of the 4-substituent in methaemoglobinaemia, the toxicity of a series of 4-substituted aniline derivatives was also studied. Of the anilines studied, 4-nitroaniline caused the most methaemoglobin (36.5 +/- 8.0%), whilst aniline caused the least (0.3 +/- 0.5%). Overall, there was a significant correlation (r2 = 0.83) between the haemotoxicity and the Hammett constant, sigma(p), suggesting that it is the electron-withdrawing properties of the substituent that influence the methaemoglobin formation. In the presence of microsomes prepared from two human livers, dapsone was the most haemotoxic bis arylamine, whereas 4-iodoaniline was the most potent methaemoglobin former (60.6 and 73.6%) and aniline the least potent (1.1 and 2.4%). As a whole, these results indicate that the sulphonyl group, which is essential for the pharmacological activity of dapsone, is also largely responsible for the haemotoxicity seen with this drug.
通过对一系列4-取代芳胺的体外生物活化研究,已确定了氨苯砜(4,4'-二氨基二苯砜)血液毒性的结构基础。在大鼠肝微粒体存在的情况下,氨苯砜(100微摩尔)是人类红细胞中高铁血红蛋白的最有效形成剂(44.8±6.7%)。砜基被硫(高铁血红蛋白形成率为11.6±1.4%)、氧(4.5±1.1%)、氮(0.0±3.2%)、碳(13.6±0.8%)或酮基(34.0±6.1%)取代后,高铁血红蛋白的形成减少。只有一种化合物,即4,4'-二氨基二苯胺,在没有NADPH的情况下产生了大量(P<0.001)的高铁血红蛋白(25.6±2.5%)。为了进一步评估4-取代基在高铁血红蛋白血症中的作用,还研究了一系列4-取代苯胺衍生物的毒性。在所研究的苯胺中,4-硝基苯胺导致的高铁血红蛋白最多(36.5±8.0%),而苯胺导致的最少(0.3±0.5%)。总体而言,血液毒性与哈米特常数σ(p)之间存在显著相关性(r2 = 0.83),这表明是取代基的吸电子特性影响了高铁血红蛋白的形成。在由两个人类肝脏制备的微粒体存在的情况下,氨苯砜是最具血液毒性的双芳基胺,而4-碘苯胺是最有效的高铁血红蛋白形成剂(分别为60.6%和73.6%),苯胺则是最无效的(分别为1.1%和2.4%)。总体而言,这些结果表明,氨苯砜药理活性所必需的磺酰基在很大程度上也是该药物所见血液毒性的原因。